Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 227

1.

Multimodal assessment of sleep in men and women during treatment for opioid use disorder.

Finan PH, Mun CJ, Epstein DH, Kowalczyk WJ, Phillips KA, Agage D, Smith MT, Preston KL.

Drug Alcohol Depend. 2020 Feb 1;207:107698. doi: 10.1016/j.drugalcdep.2019.107698. Epub 2019 Nov 18.

PMID:
31816489
2.

Craving and opioid use disorder: A scoping review.

Kleykamp BA, De Santis M, Dworkin RH, Huhn AS, Kampman KM, Montoya ID, Preston KL, Ramey T, Smith SM, Turk DC, Walsh R, Weiss RD, Strain EC.

Drug Alcohol Depend. 2019 Dec 1;205:107639. doi: 10.1016/j.drugalcdep.2019.107639. Epub 2019 Oct 17. Review.

PMID:
31683241
3.

Sleep reductions associated with illicit opioid use and clinic-hour changes during opioid agonist treatment for opioid dependence: Measurement by electronic diary and actigraphy.

Bertz JW, Epstein DH, Reamer D, Kowalczyk WJ, Phillips KA, Kennedy AP, Jobes ML, Ward G, Plitnick BA, Figueiro MG, Rea MS, Preston KL.

J Subst Abuse Treat. 2019 Nov;106:43-57. doi: 10.1016/j.jsat.2019.08.011. Epub 2019 Aug 14.

PMID:
31540611
4.

Stress, craving and mood as predictors of early dropout from opioid agonist therapy.

Panlilio LV, Stull SW, Kowalczyk WJ, Phillips KA, Schroeder JR, Bertz JW, Vahabzadeh M, Lin JL, Mezghanni M, Nunes EV, Epstein DH, Preston KL.

Drug Alcohol Depend. 2019 Sep 1;202:200-208. doi: 10.1016/j.drugalcdep.2019.05.026. Epub 2019 Jul 16.

PMID:
31357121
5.

Defining and Predicting Opioid and Cocaine Treatment Response.

Gardner RA, Epstein DH, Preston KL, Phillips KA.

Subst Use Misuse. 2019;54(13):2134-2143. doi: 10.1080/10826084.2019.1638405. Epub 2019 Jul 18.

PMID:
31315479
6.

Towards detecting cocaine use using smartwatches in the NIDA clinical trials network: Design, rationale, and methodology.

Holtyn AF, Bosworth E, Marsch LA, McLeman B, Meier A, Saunders EC, Ertin E, Ullah MA, Samiei SA, Hossain M, Kumar S, Preston KL, Vahabzadeh M, Shmueli-Blumberg D, Collins J, McCormack J, Ghitza UE.

Contemp Clin Trials Commun. 2019 Jun 4;15:100392. doi: 10.1016/j.conctc.2019.100392. eCollection 2019 Sep.

7.

The chippers, the quitters, and the highly symptomatic: A 12-month longitudinal study of DSM-5 opioid- and cocaine-use problems in a community sample.

Stull SW, Panlilio LV, Moran LM, Schroeder JR, Bertz JW, Epstein DH, Preston KL, Phillips KA.

Addict Behav. 2019 Sep;96:183-191. doi: 10.1016/j.addbeh.2019.04.030. Epub 2019 Apr 29.

PMID:
31108264
8.

Striatal Dopamine Release in Response to Morphine: A [11C]Raclopride Positron Emission Tomography Study in Healthy Men.

Spagnolo PA, Kimes A, Schwandt ML, Shokri-Kojori E, Thada S, Phillips KA, Diazgranados N, Preston KL, Herscovitch P, Tomasi D, Ramchandani VA, Heilig M.

Biol Psychiatry. 2019 Sep 1;86(5):356-364. doi: 10.1016/j.biopsych.2019.03.965. Epub 2019 Mar 15.

PMID:
31097294
9.

Distinguishing recent dispersal from historical genetic connectivity in the coastal California gnatcatcher.

Vandergast AG, Kus BE, Preston KL, Barr KR.

Sci Rep. 2019 Feb 4;9(1):1355. doi: 10.1038/s41598-018-37712-2.

10.

Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African-Americans with opioid use disorder.

Crist RC, Phillips KA, Furnari MA, Moran LM, Doyle GA, McNicholas LF, Cornish JW, Kampman KM, Preston KL, Berrettini WH.

Pharmacogenomics J. 2019 Jun;19(3):260-268. doi: 10.1038/s41397-018-0065-x. Epub 2018 Oct 27.

11.

End-of-day reports of daily hassles and stress in men and women with opioid-use disorder: Relationship to momentary reports of opioid and cocaine use and stress.

Preston KL, Schroeder JR, Kowalczyk WJ, Phillips KA, Jobes ML, Dwyer M, Vahabzadeh M, Lin JL, Mezghanni M, Epstein DH.

Drug Alcohol Depend. 2018 Dec 1;193:21-28. doi: 10.1016/j.drugalcdep.2018.08.023. Epub 2018 Oct 11.

12.

Prioritizing conserved areas threatened by wildfire and fragmentation for monitoring and management.

Tracey JA, Rochester CJ, Hathaway SA, Preston KL, Syphard AD, Vandergast AG, Diffendorfer JE, Franklin J, MacKenzie JB, Oberbauer TA, Tremor S, Winchell CS, Fisher RN.

PLoS One. 2018 Sep 7;13(9):e0200203. doi: 10.1371/journal.pone.0200203. eCollection 2018.

13.

Prevention and Treatment of Opioid Overdose and Opioid-Use Disorders.

Phillips KA, Preston KL.

Addict Behav. 2018 Nov;86:1-3. doi: 10.1016/j.addbeh.2018.07.013. No abstract available.

PMID:
30080480
14.

Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder.

Schroeder JR, Phillips KA, Epstein DH, Jobes ML, Furnari MA, Kennedy AP, Heilig M, Preston KL.

Psychopharmacology (Berl). 2018 Oct;235(10):2957-2966. doi: 10.1007/s00213-018-4986-5. Epub 2018 Aug 6.

PMID:
30079432
15.

Before and after: craving, mood, and background stress in the hours surrounding drug use and stressful events in patients with opioid-use disorder.

Preston KL, Kowalczyk WJ, Phillips KA, Jobes ML, Vahabzadeh M, Lin JL, Mezghanni M, Epstein DH.

Psychopharmacology (Berl). 2018 Sep;235(9):2713-2723. doi: 10.1007/s00213-018-4966-9. Epub 2018 Jul 7.

16.

Using mobile location data in biomedical research while preserving privacy.

Goldenholz DM, Goldenholz SR, Krishnamurthy KB, Halamka J, Karp B, Tyburski M, Wendler D, Moss R, Preston KL, Theodore W.

J Am Med Inform Assoc. 2018 Oct 1;25(10):1402-1406. doi: 10.1093/jamia/ocy071.

17.

Does human language limit translatability of clinical and preclinical addiction research?

de Wit H, Epstein DH, Preston KL.

Neuropsychopharmacology. 2018 Sep;43(10):1985-1988. doi: 10.1038/s41386-018-0095-8. Epub 2018 May 17. No abstract available.

18.

Sex differences in daily life stress and craving in opioid-dependent patients.

Moran LM, Kowalczyk WJ, Phillips KA, Vahabzadeh M, Lin JL, Mezghanni M, Epstein DH, Preston KL.

Am J Drug Alcohol Abuse. 2018;44(5):512-523. doi: 10.1080/00952990.2018.1454934. Epub 2018 Apr 11.

19.

Using ecological momentary assessment to examine the relationship between craving and affect with opioid use in a clinical trial of clonidine as an adjunct medication to buprenorphine treatment.

Kowalczyk WJ, Moran LM, Bertz JW, Phillips KA, Ghitza UE, Vahabzadeh M, Lin JL, Epstein DH, Preston KL.

Am J Drug Alcohol Abuse. 2018;44(5):502-511. doi: 10.1080/00952990.2018.1454933. Epub 2018 Apr 10.

20.

Combining ecological momentary assessment with objective, ambulatory measures of behavior and physiology in substance-use research.

Bertz JW, Epstein DH, Preston KL.

Addict Behav. 2018 Aug;83:5-17. doi: 10.1016/j.addbeh.2017.11.027. Epub 2017 Nov 16. Review.

21.

Exacerbated Craving in the Presence of Stress and Drug Cues in Drug-Dependent Patients.

Preston KL, Kowalczyk WJ, Phillips KA, Jobes ML, Vahabzadeh M, Lin JL, Mezghanni M, Epstein DH.

Neuropsychopharmacology. 2018 Mar;43(4):859-867. doi: 10.1038/npp.2017.275. Epub 2017 Nov 6.

22.

Perceptions of Neighborhood Mediate the Relationship Between PTSD Symptoms and Coping in a Neighborhood-Matched Substance-Using Sample.

Hertzel SK, Schroeder J, Moran LM, Alvanzo AA, Kowalczyk WJ, Epstein DH, Preston KL, Phillips KA.

J Addict Med. 2017 Nov/Dec;11(6):440-448. doi: 10.1097/ADM.0000000000000343.

23.

Clonidine Increases the Likelihood That Abstinence Can Withstand Unstructured Time in Buprenorphine-maintained Outpatients.

Kowalczyk WJ, Bertz JW, Moran LM, Phillips KA, Ghitza UE, Epstein DH, Preston KL.

J Addict Med. 2017 Nov/Dec;11(6):454-460. doi: 10.1097/ADM.0000000000000345.

24.

Context and craving during stressful events in the daily lives of drug-dependent patients.

Preston KL, Kowalczyk WJ, Phillips KA, Jobes ML, Vahabzadeh M, Lin JL, Mezghanni M, Epstein DH.

Psychopharmacology (Berl). 2017 Sep;234(17):2631-2642. doi: 10.1007/s00213-017-4663-0. Epub 2017 Jun 8.

25.

A role for muscarinic receptors in neutrophil extracellular trap formation and levamisole-induced autoimmunity.

Carmona-Rivera C, Purmalek MM, Moore E, Waldman M, Walter PJ, Garraffo HM, Phillips KA, Preston KL, Graf J, Kaplan MJ, Grayson PC.

JCI Insight. 2017 Feb 9;2(3):e89780. doi: 10.1172/jci.insight.89780.

26.

Finding Significant Stress Episodes in a Discontinuous Time Series of Rapidly Varying Mobile Sensor Data.

Sarker H, Tyburski M, Rahman MM, Hovsepian K, Sharmin M, Epstein DH, Preston KL, Furr-Holden CD, Milam A, Nahum-Shani I, al'Absi M, Kumar S.

Proc SIGCHI Conf Hum Factor Comput Syst. 2016 May;2016:4489-4501. doi: 10.1145/2858036.2858218.

27.

Aripiprazole for cocaine abstinence: a randomized-controlled trial with ecological momentary assessment.

Moran LM, Phillips KA, Kowalczyk WJ, Ghitza UE, Agage DA, Epstein DH, Preston KL.

Behav Pharmacol. 2017 Feb;28(1):63-73. doi: 10.1097/FBP.0000000000000268.

28.

Effect of the CRF1-receptor antagonist pexacerfont on stress-induced eating and food craving.

Epstein DH, Kennedy AP, Furnari M, Heilig M, Shaham Y, Phillips KA, Preston KL.

Psychopharmacology (Berl). 2016 Dec;233(23-24):3921-3932. Epub 2016 Sep 5.

29.

Real-time assessment of alcohol drinking and drug use in opioid-dependent polydrug users.

Preston KL, Jobes ML, Phillips KA, Epstein DH.

Behav Pharmacol. 2016 Oct;27(7):579-84. doi: 10.1097/FBP.0000000000000250.

30.

Using iPSC-derived human DA neurons from opioid-dependent subjects to study dopamine dynamics.

Sheng Y, Filichia E, Shick E, Preston KL, Phillips KA, Cooperman L, Lin Z, Tesar P, Hoffer B, Luo Y.

Brain Behav. 2016 May 25;6(8):e00491. doi: 10.1002/brb3.491. eCollection 2016 Aug.

31.

Lower Dopamine D2 Receptor Expression Levels in Human Dopaminergic Neurons Derived From Opioid-Dependent iPSCs.

Sheng Y, Filichia E, Shick E, Preston KL, Phillips KA, Cooperman L, Lin Z, Tesar P, Hoffer BJ, Luo Y.

Am J Psychiatry. 2016 Apr 1;173(4):429-31. doi: 10.1176/appi.ajp.2015.15121545. No abstract available.

32.

Measures of outcome for stimulant trials: ACTTION recommendations and research agenda.

Kiluk BD, Carroll KM, Duhig A, Falk DE, Kampman K, Lai S, Litten RZ, McCann DJ, Montoya ID, Preston KL, Skolnick P, Weisner C, Woody G, Chandler R, Detke MJ, Dunn K, Dworkin RH, Fertig J, Gewandter J, Moeller FG, Ramey T, Ryan M, Silverman K, Strain EC.

Drug Alcohol Depend. 2016 Jan 1;158:1-7. doi: 10.1016/j.drugalcdep.2015.11.004. Epub 2015 Nov 21. Review.

33.

Cognitive-behavioural therapy for heroin and cocaine use: Ecological momentary assessment of homework simplification and compliance.

Willner-Reid J, Whitaker D, Epstein DH, Phillips KA, Pulaski AR, Preston KL, Willner P.

Psychol Psychother. 2016 Sep;89(3):276-93. doi: 10.1111/papt.12080. Epub 2015 Nov 4.

34.

Effects of Prereactivation Propranolol on Cocaine Craving Elicited by Imagery Script/Cue Sets in Opioid-dependent Polydrug Users: A Randomized Study.

Jobes ML, Aharonovich E, Epstein DH, Phillips KA, Reamer D, Anderson M, Preston KL.

J Addict Med. 2015 Nov-Dec;9(6):491-8. doi: 10.1097/ADM.0000000000000169.

35.

Some of the people, some of the time: field evidence for associations and dissociations between stress and drug use.

Furnari M, Epstein DH, Phillips KA, Jobes ML, Kowalczyk WJ, Vahabzadeh M, Lin JL, Preston KL.

Psychopharmacology (Berl). 2015 Oct;232(19):3529-37. doi: 10.1007/s00213-015-3998-7. Epub 2015 Jul 9.

PMID:
26153066
36.

Continuous in-the-field measurement of heart rate: Correlates of drug use, craving, stress, and mood in polydrug users.

Kennedy AP, Epstein DH, Jobes ML, Agage D, Tyburski M, Phillips KA, Ali AA, Bari R, Hossain SM, Hovsepian K, Rahman MM, Ertin E, Kumar S, Preston KL.

Drug Alcohol Depend. 2015 Jun 1;151:159-66. doi: 10.1016/j.drugalcdep.2015.03.024. Epub 2015 Apr 7.

37.

No evidence for reduction of opioid-withdrawal symptoms by cannabis smoking during a methadone dose taper.

Epstein DH, Preston KL.

Am J Addict. 2015 Jun;24(4):323-8. doi: 10.1111/ajad.12183. Epub 2015 Apr 6.

38.

Tailored, interactive text messages for enhancing weight loss among African American adults: the TRIMM randomized controlled trial.

Lin M, Mahmooth Z, Dedhia N, Frutchey R, Mercado CE, Epstein DH, Preston KL, Gibbons MC, Bowie JV, Labrique AB, Cheskin LJ.

Am J Med. 2015 Aug;128(8):896-904. doi: 10.1016/j.amjmed.2015.03.013. Epub 2015 Mar 31.

PMID:
25840035
39.

Habitat fragmentation in coastal southern California disrupts genetic connectivity in the cactus wren (Campylorhynchus brunneicapillus).

Barr KR, Kus BE, Preston KL, Howell S, Perkins E, Vandergast AG.

Mol Ecol. 2015 May;24(10):2349-63. doi: 10.1111/mec.13176. Epub 2015 Apr 20.

PMID:
25819510
40.

Clonidine Maintenance Prolongs Opioid Abstinence and Decouples Stress From Craving in Daily Life: A Randomized Controlled Trial With Ecological Momentary Assessment.

Kowalczyk WJ, Phillips KA, Jobes ML, Kennedy AP, Ghitza UE, Agage DA, Schmittner JP, Epstein DH, Preston KL.

Am J Psychiatry. 2015 Aug 1;172(8):760-7. doi: 10.1176/appi.ajp.2014.14081014. Epub 2015 Mar 17.

41.

Substance use and hepatitis C: an ecological momentary assessment study.

Phillips KA, Epstein DH, Vahabzadeh M, Mezghanni M, Lin JL, Preston KL.

Health Psychol. 2014 Jul;33(7):710-9. doi: 10.1037/hea0000087.

42.

Psychostimulant addiction treatment.

Phillips KA, Epstein DH, Preston KL.

Neuropharmacology. 2014 Dec;87:150-60. doi: 10.1016/j.neuropharm.2014.04.002. Epub 2014 Apr 12. Review.

43.

Are We There Yet? Feasibility of Continuous Stress Assessment via Wireless Physiological Sensors.

Rahman M, Bari R, Ali AA, Sharmin M, Raij A, Hovsepian K, Hossain SM, Ertin E, Kennedy A, Epstein DH, Preston KL, Jobes M, Beck JG, Kedia S, Ward KD, al'Absi M, Kumar S.

ACM BCB. 2014;2014:479-488.

44.

Real-time tracking of neighborhood surroundings and mood in urban drug misusers: application of a new method to study behavior in its geographical context.

Epstein DH, Tyburski M, Craig IM, Phillips KA, Jobes ML, Vahabzadeh M, Mezghanni M, Lin JL, Furr-Holden CDM, Preston KL.

Drug Alcohol Depend. 2014 Jan 1;134:22-29. doi: 10.1016/j.drugalcdep.2013.09.007. Epub 2013 Sep 14.

45.

Smartphone Delivery of Mobile HIV Risk Reduction Education.

Phillips KA, Epstein DH, Mezghanni M, Vahabzadeh M, Reamer D, Agage D, Preston KL.

AIDS Res Treat. 2013;2013:231956. doi: 10.1155/2013/231956. Epub 2013 Sep 17.

46.
47.

Daily temporal patterns of heroin and cocaine use and craving: relationship with business hours regardless of actual employment status.

Phillips KA, Epstein DH, Preston KL.

Addict Behav. 2013 Oct;38(10):2485-91. doi: 10.1016/j.addbeh.2013.05.010. Epub 2013 May 22.

48.

Sex differences in cocaine/heroin users: drug-use triggers and craving in daily life.

Kennedy AP, Epstein DH, Phillips KA, Preston KL.

Drug Alcohol Depend. 2013 Sep 1;132(1-2):29-37. doi: 10.1016/j.drugalcdep.2012.12.025. Epub 2013 Jan 26.

49.

Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humans.

Huestis MA, Cone EJ, Pirnay SO, Umbricht A, Preston KL.

Drug Alcohol Depend. 2013 Aug 1;131(3):258-62. doi: 10.1016/j.drugalcdep.2012.11.014. Epub 2012 Dec 14.

50.

A randomized investigation of methadone doses at or over 100 mg/day, combined with contingency management.

Kennedy AP, Phillips KA, Epstein DH, Reamer DA, Schmittner J, Preston KL.

Drug Alcohol Depend. 2013 Jun 1;130(1-3):77-84. doi: 10.1016/j.drugalcdep.2012.10.025. Epub 2012 Nov 26.

Supplemental Content

Loading ...
Support Center